Youngbo Chemical Co., Ltd. (KRX:014440)
South Korea · Delayed Price · Currency is KRW 4,405.00
-15.00 (-0.34%)
Jun 2, 2026, 3:30 PM KST
Youngbo Chemical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 122,075 | 120,111 | 117,567 | 90,279 | 82,989 | 76,803 | |
Revenue Growth (YoY) | 3.82% | 2.16% | 30.23% | 8.78% | 8.05% | -28.47% |
Cost of Revenue | 85,467 | 83,287 | 81,703 | 67,588 | 62,832 | 56,796 |
Gross Profit | 36,609 | 36,824 | 35,863 | 22,691 | 20,157 | 20,007 |
Selling, General & Admin | 13,802 | 13,829 | 13,439 | 12,666 | 11,142 | 12,132 |
Research & Development | 2,334 | 2,276 | 1,816 | 1,975 | 1,951 | 1,903 |
Amortization of Goodwill & Intangibles | 448.36 | 470.71 | 468.77 | 460.22 | 472.9 | 518.1 |
Other Operating Expenses | 590.47 | 539.03 | 326.63 | 323.5 | 1,118 | 495.64 |
Operating Expenses | 17,614 | 17,535 | 16,461 | 15,741 | 15,184 | 15,638 |
Operating Income | 18,994 | 19,289 | 19,402 | 6,951 | 4,973 | 4,369 |
Interest Expense | -6.21 | -6.56 | -35.01 | -95.42 | -189.81 | -240.06 |
Interest & Investment Income | 1,108 | 1,400 | 1,469 | 868.09 | 680.42 | 215.89 |
Currency Exchange Gain (Loss) | 811.46 | 192.62 | 966.08 | 98.88 | 103.11 | 600.44 |
Other Non Operating Income (Expenses) | -50.89 | -52.81 | -30.75 | -177.02 | -1,341 | -116.31 |
EBT Excluding Unusual Items | 20,856 | 20,822 | 21,772 | 7,645 | 4,226 | 4,829 |
Gain (Loss) on Sale of Investments | -0.13 | -0.13 | 0.42 | 0.86 | 0.25 | 1.52 |
Gain (Loss) on Sale of Assets | 375.73 | -20.16 | 52.53 | -182.91 | 3,285 | -775.82 |
Asset Writedown | -60 | -60 | -21 | -468.67 | -16 | -317.73 |
Pretax Income | 21,172 | 20,742 | 21,804 | 6,994 | 7,496 | 3,737 |
Income Tax Expense | 4,732 | 3,912 | 2,752 | 915.55 | 414.99 | 1,394 |
Earnings From Continuing Operations | 16,440 | 16,830 | 19,051 | 6,079 | 7,081 | 2,344 |
Earnings From Discontinued Operations | - | - | 3,502 | -118.01 | -391.35 | 1,158 |
Net Income to Company | 16,440 | 16,830 | 22,554 | 5,961 | 6,689 | 3,502 |
Net Income | 16,440 | 16,830 | 22,554 | 5,961 | 6,689 | 3,502 |
Net Income to Common | 16,440 | 16,830 | 22,554 | 5,961 | 6,689 | 3,502 |
Net Income Growth | -17.36% | -25.38% | 278.37% | -10.89% | 91.03% | 23.21% |
Shares Outstanding (Basic) | 20 | 20 | 19 | 20 | 20 | 20 |
Shares Outstanding (Diluted) | 20 | 20 | 19 | 20 | 20 | 20 |
Shares Change (YoY) | 0.05% | 0.03% | -0.03% | - | - | - |
EPS (Basic) | 843.04 | 863.07 | 1157.00 | 305.68 | 343.04 | 179.58 |
EPS (Diluted) | 843.04 | 863.07 | 1157.00 | 305.68 | 343.04 | 179.58 |
EPS Growth | -17.41% | -25.41% | 278.50% | -10.89% | 91.03% | 23.21% |
Free Cash Flow | 5,478 | 7,305 | 14,107 | 10,818 | -1,628 | 9,501 |
Free Cash Flow Per Share | 280.89 | 374.60 | 723.68 | 554.78 | -83.50 | 487.22 |
Dividend Per Share | - | - | - | 50.000 | 50.000 | 100.000 |
Dividend Growth | - | - | - | - | -50.00% | 33.33% |
Gross Margin | 29.99% | 30.66% | 30.50% | 25.14% | 24.29% | 26.05% |
Operating Margin | 15.56% | 16.06% | 16.50% | 7.70% | 5.99% | 5.69% |
Profit Margin | 13.47% | 14.01% | 19.18% | 6.60% | 8.06% | 4.56% |
Free Cash Flow Margin | 4.49% | 6.08% | 12.00% | 11.98% | -1.96% | 12.37% |
EBITDA | 28,163 | 28,191 | 28,126 | 15,260 | 13,632 | 13,166 |
EBITDA Margin | 23.07% | 23.47% | 23.92% | 16.90% | 16.43% | 17.14% |
D&A For EBITDA | 9,169 | 8,902 | 8,723 | 8,310 | 8,658 | 8,796 |
EBIT | 18,994 | 19,289 | 19,402 | 6,951 | 4,973 | 4,369 |
EBIT Margin | 15.56% | 16.06% | 16.50% | 7.70% | 5.99% | 5.69% |
Effective Tax Rate | 22.35% | 18.86% | 12.62% | 13.09% | 5.54% | 37.29% |
Advertising Expenses | - | 83.68 | 118.35 | 69.87 | 50.48 | 26.96 |